Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
Go back to Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit| (NASDAQ: BLTE) | Delayed: 138.16 +1.31 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $136.85 | 52 Week High | $ | |||
| Open | $137.34 | 52 Week Low | $ | |||
| Day High | $139.00 | P/E | N/A | |||
| Day Low | $135.36 | EPS | $ | |||
| Volume | 154,909 | |||||

